{"id":"09387f1a-bebb-4550-96e3-0c6c4cad027b","slug":"decrawhere-do-we-go-from-here","title":"DECRA…Where do we go from here?","authors":["Roland Torres"],"abstract":"Background: In the United States, approximately two million head injuries occur annually, with significant economic implications. The DECRA trial, published in 2011, investigated the effects of early decompressive craniectomy in patients with severe diffuse traumatic brain injury and refractory intracranial hypertension. The trial has generated considerable debate regarding its findings and implications for clinical practice. Methods: The DECRA trial screened 3478 patients, ultimately enrolling 155 individuals with severe diffuse TBI and refractory intracranial hypertension. Participants were randomly assigned to receive either early decompressive craniectomy or standard care therapy. The study primarily focused on intracranial pressure management and clinical outcomes. Results: Patients who underwent decompressive craniectomy experienced reduced time with elevated intracranial pressures, fewer interventions for ICP management, and shorter ICU stays. However, these patients demonstrated worse outcomes on the Extended Glasgow Outcome Scale and similar mortality rates compared to the standard care group. Conclusion: The DECRA trial suggests that while decompressive craniectomy can effectively lower intracranial pressure, it may not improve overall outcomes for patients with severe diffuse traumatic brain injury. The findings highlight the need for further research to establish optimal management strategies for this patient population. Keywords: decompressive craniectomy, traumatic brain injury, intracranial pressure, clinical outcomes, neurosurgery, DECRA trial","thumbnailUrl":null,"publishDate":"2012-05-14T00:00:00.000Z","doi":"10.4103/2152-7806.96150","categories":["Original Article"],"fullTextUrl":"http://sni.wpengine.com/wp-content/uploads/2015/05/3342/SNI-3-54.pdf"}